Rocket Pharmaceuticals, Inc. ( RCKT) - Stock Earnings
RCKT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 10, 2026 AfterMarket | -0.15 / — | — | — / — | — |
RCKT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -50.3 million USD | — USD |
| 2025Q4 | -42.5 million USD | — USD |
| 2026Q1 | -47.6 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
RCKT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -245.6 million USD | — USD |
| 2024 | -258.7 million USD | — USD |
| 2025 | -223.1 million USD | — USD |
| 2026 Est. | — | — |
RCKT
Price: $3.41
52 week price:
Earnings Per Share: -1.90 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 607900
Market Capitalization: 382.2 million